AZD4205
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for AZD4205, covering 2020-08-24 to 2025-12-31. Get the full timeline:
Most recent: Clinical Trial Update: A Phase II Clinical Trial of DZD9008 in Combination With AZD4205 in Standard Treatment Failed NSCLC Patients With EGFR Mutations (WU-KONG21) [Phase 2]